
-
Indian capital bans fuel for old cars in anti-pollution bid
-
Flintoff rules himself out of top England coaching job
-
Russia ramps up drone strikes on Ukraine in June: AFP analysis
-
Japan had hottest June on record: weather agency
-
Asian stocks rise on trade deal hopes, Tokyo hit by Trump warning
-
Thailand's PM suspended by Constitutional Court
-
Blur will return to musical oasis, says drummer Rowntree
-
CBEX crypto scam: AI-hyped Ponzi scheme defrauds African investors
-
Inzaghi hails 'extraordinary' Al Hilal after City upset
-
Man City, Inter Milan crash out of Club World Cup in last 16
-
North Korea's Kim shown honouring troops killed in Russia-Ukraine war
-
Saudi's Al Hilal knock Man City out of Club World Cup in huge shock
-
'In our blood': Egyptian women reclaim belly dance from stigma
-
Online memorial for children dead in Hiroshima, Nagasaki
-
US Senate in final push to pass Trump spending bill
-
Asian stocks rise on trade deal hopes, Tokyo hit by tariff warning
-
Hong Kong rights record under fire as it marks China handover anniversary
-
Bangladeshis cling to protest dreams a year after revolution
-
Djokovic, Sinner enter Wimbledon fray
-
European security tops Denmark's EU presidency priorities
-
France expecting peak temperatures as heatwave hits Europe
-
Germany eye return to women's football summit at Euro 2025
-
'Every day I see land disappear': Suriname's battle to keep sea at bay
-
England feel pressure to perform at Euros as stars pull out
-
Clashes in Istanbul over alleged 'Prophet Mohammed' cartoon
-
India face 'last-minute' Bumrah call as they bid to level England series
-
Dortmund up against 'superstar' Ramos, aggressive Monterrey: Kovac
-
US judge orders Argentina to sell 51% stake in oil firm YPF
-
DEA BUSTED!! While Chinese Marijuana Cartels Spread Right Under DEA's Nose, FDA CANNABIS RESEARCH BLOCKED
-
Proenkephalin A 119-159 (penKid) Leads the Way in Predicting Graft Outcomes for Kidney Transplant Recipients
-
DASA, Latin America's Largest Diagnostic Provider, Selects AGFA HealthCare's Enterprise Imaging Platform in Flagship Agreement
-
Record Financing for NeXtWind: €1.4 Billion for the Expansion of Wind Energy in Germany
-
Pantheon Resources PLC Announces Change of Registered Office
-
EPA employees accuse Trump administration of 'ignoring' science
-
US Senate in final slog towards vote on Trump spending bill
-
Over 14 million people could die from US foreign aid cuts: study
-
End of the line for Britain's royal train
-
FIFPro warns of 'wake-up call' over extreme heat at Club World Cup
-
Sean Combs sex trafficking jury ends first day without decision
-
Fluminense stun Inter Milan to reach Club World Cup quarters
-
Thailand's ruling political dynasty faces day of legal peril
-
NASA eyes summer streaming liftoff on Netflix
-
Trump dismantles Syria sanctions program as Israel ties eyed
-
Meta's AI talent war raises questions about strategy
-
Twenty bodies, some headless, found in Mexican cartel bastion
-
Gaza rescuers say Israeli forces kill over 50 as ceasefire calls mount
-
Alcaraz survives scare, Sabalenka cruises on Wimbledon's hottest opening day
-
Only Messi can shirk defending: warns Monterrey coach before Dortmund clash
-
White House says Canada 'caved' to Trump on tech tax
-
Eight-country coalition aims to tax luxury air travel

US judges appear skeptical of preserving access to abortion pill
A US federal appeals court panel appeared skeptical on Wednesday of preserving access to a widely used abortion pill.
The three conservative judges pushed back against government arguments that the decision on whether to allow the use of mifepristone should be left to the Food and Drug Administration (FDA), which approved the drug more than 20 years ago.
"We are allowed to look at the FDA just like we're allowed to look at any agency," said Judge James Ho. "That's the role of the courts."
Anti-abortion groups are seeking to have mifepristone banned, claiming despite its long track record that it is unsafe. The case is the latest skirmish in the battle over reproductive rights in the United States.
Ho and one of the other judges on the panel of the New Orleans-based 5th Circuit Court of Appeals were appointed by former president Donald Trump, while the third was also named by a Republican president, George W. Bush.
All three judges seemed unconvinced by arguments by the Justice Department of Democratic President Joe Biden and lawyers for mifepristone manufacturer Danco that the drug should be allowed to remain on the market.
The case stems from a ruling by a conservative US District Court judge in Texas that would have banned mifepristone, which accounts for more than half of the abortions in the United States.
The 5th Circuit Court blocked a ban on the abortion pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court temporarily preserved access to mifepristone, freezing the rulings by the lower courts, and sent the case back to the 5th Circuit.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, was pessimistic following Wednesday's hearing.
"The arguments today demonstrated in detail that the case has no legal or scientific merit and should have been laughed out of court from the very start," Dalven said.
"Unfortunately, the deck is stacked as the judges hearing this case are well known for their extraordinary hostility to abortion," Dalven said.
Any ruling by the appellate court is likely to eventually reach the Supreme Court, which overturned the constitutional right to abortion 11 months ago.
Since then, more than a dozen states have banned abortion and it has been severely restricted in others.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved in 2000.
B.Finley--AMWN